Mark W. Farmen

1.3k total citations
26 papers, 1.0k citations indexed

About

Mark W. Farmen is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Mark W. Farmen has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Computational Theory and Mathematics. Recurrent topics in Mark W. Farmen's work include Drug Transport and Resistance Mechanisms (5 papers), Computational Drug Discovery Methods (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Mark W. Farmen is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Computational Drug Discovery Methods (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Mark W. Farmen collaborates with scholars based in United States, Singapore and United Kingdom. Mark W. Farmen's co-authors include Irène Gijbels, Jianqing Fan, Paul L. Brown, Christophe G Lambert, S. Stanley Young, Andrew Rusinko, Sandra Close, Carmen M. Dumaual, Richard D. Hockett and Brian J. Eastwood and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and Clinical Chemistry.

In The Last Decade

Mark W. Farmen

26 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark W. Farmen United States 16 334 187 137 131 112 26 1.0k
Bengt Hamrén Sweden 13 301 0.9× 169 0.9× 77 0.6× 94 0.7× 64 0.6× 41 958
Jane P. F. Bai United States 25 553 1.7× 236 1.3× 283 2.1× 105 0.8× 59 0.5× 72 1.4k
Omri Gottesman United States 19 519 1.6× 119 0.6× 57 0.4× 165 1.3× 88 0.8× 23 1.6k
Mark Sale United States 18 257 0.8× 74 0.4× 226 1.6× 73 0.6× 140 1.3× 42 1.1k
Marylore Chenel France 17 218 0.7× 129 0.7× 225 1.6× 180 1.4× 53 0.5× 52 975
June S. Almenoff United States 18 457 1.4× 198 1.1× 337 2.5× 77 0.6× 50 0.4× 36 1.5k
Lisa J. Benincosa United States 14 248 0.7× 92 0.5× 83 0.6× 92 0.7× 69 0.6× 29 804
Hao Zhu United States 18 315 0.9× 171 0.9× 141 1.0× 177 1.4× 129 1.2× 66 1.3k
Wojciech Krzyżański United States 27 658 2.0× 135 0.7× 354 2.6× 233 1.8× 65 0.6× 115 2.1k
Rajanikanth Madabushi United States 19 443 1.3× 196 1.0× 285 2.1× 333 2.5× 274 2.4× 58 1.8k

Countries citing papers authored by Mark W. Farmen

Since Specialization
Citations

This map shows the geographic impact of Mark W. Farmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Farmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Farmen more than expected).

Fields of papers citing papers by Mark W. Farmen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Farmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Farmen. The network helps show where Mark W. Farmen may publish in the future.

Co-authorship network of co-authors of Mark W. Farmen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Farmen. A scholar is included among the top collaborators of Mark W. Farmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Farmen. Mark W. Farmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Byrd, Richard A., Rebecca A. Owens, Jamie L. Blackbourne, et al.. (2017). Nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (BASAGLAR®/ABASAGLAR®) approved in the European Union. Regulatory Toxicology and Pharmacology. 88. 56–65. 4 indexed citations
2.
Pillai, Sreekumar, Suman Duvvuru, Pallav Bhatnagar, et al.. (2017). The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro. The Pharmacogenomics Journal. 18(3). 487–493. 13 indexed citations
3.
4.
Owens, Robyn, R. J. Hansen, Steven D. Kahl, et al.. (2016). In Vivo and In Vitro Characterization of Basal Insulin Peglispro: A Novel Insulin Analog. Journal of Pharmacology and Experimental Therapeutics. 357(3). 459–465. 15 indexed citations
5.
Guo, Yingying, et al.. (2014). Deciphering ADME genetic data using an automated haplotype approach. Pharmacogenetics and Genomics. 24(6). 292–305. 1 indexed citations
6.
Cohn, Allen Lee, Michael Lahn, Ann Cleverly, et al.. (2014). A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer. International Journal of Oncology. 45(6). 2221–2231. 37 indexed citations
7.
Kadam, Sunil, Mark W. Farmen, & John T. Brandt. (2012). Quantitative Measurement of Cell-Free Plasma DNA and Applications for Detecting Tumor Genetic Variation and Promoter Methylation in a Clinical Setting. Journal of Molecular Diagnostics. 14(4). 346–356. 21 indexed citations
8.
Beck, Benoît, Yunfei Chen, Viswanath Devanarayan, et al.. (2012). Assay Operations for SAR Support. Europe PMC (PubMed Central). 14 indexed citations
9.
Iversen, Philip W., Benoît Beck, Yunfei Chen, et al.. (2012). HTS Assay Validation. 61 indexed citations
10.
Man, Michael, Mark W. Farmen, Carmen M. Dumaual, et al.. (2010). Genetic Variation in Metabolizing Enzyme and Transporter Genes: Comprehensive Assessment in 3 Major East Asian Subpopulations With Comparison to Caucasians and Africans. The Journal of Clinical Pharmacology. 50(8). 929–940. 170 indexed citations
11.
Tzeng, Jung‐Ying, Wenbin Lu, Mark W. Farmen, Youfang Liu, & Patrick F. Sullivan. (2010). Haplotype-Based Pharmacogenetic Analysis for Longitudinal Quantitative Traits in the Presence of Dropout. Journal of Biopharmaceutical Statistics. 20(2). 334–350. 2 indexed citations
12.
Perlis, Roy H., David Adams, Bonnie A. Fijal, et al.. (2009). Genetic Association Study of Treatment Response With Olanzapine/Fluoxetine Combination or Lamotrigine in Bipolar I Depression. The Journal of Clinical Psychiatry. 71(5). 599–605. 33 indexed citations
13.
Farmen, Mark W., et al.. (2009). Translation of Drug Metabolic Enzyme and Transporter (DMET) Genetic Variants into Star Allele Notation using SAS. 2 indexed citations
14.
15.
Eastwood, Brian J., Mark W. Farmen, Philip W. Iversen, et al.. (2006). The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies. SLAS DISCOVERY. 11(3). 253–261. 100 indexed citations
16.
Daly, Thomas M., et al.. (2005). Precision Profiling and Components of Variability Analysis for Affymetrix Microarray Assays Run in a Clinical Context. Journal of Molecular Diagnostics. 7(3). 404–412. 15 indexed citations
17.
Evans, Glenn F., et al.. (2005). Post-transcriptional regulation of macrophage ABCA1, an early response gene to IFN-γ. Biochemical and Biophysical Research Communications. 333(2). 596–602. 16 indexed citations
18.
Larkin, Jonathan, Ling Jin, Mark W. Farmen, et al.. (2003). Synergistic Antiviral Activity of Human Interferon Combinations in the Hepatitis C Virus Replicon System. Journal of Interferon & Cytokine Research. 23(5). 247–257. 56 indexed citations
19.
Sheehan, Scott M., John J. Masters, Michael R. Wiley, et al.. (2003). A four component coupling strategy for the synthesis of d-phenylglycinamide-derived non-covalent factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(14). 2255–2259. 18 indexed citations
20.
Farmen, Mark W. & J. S. Marron. (1999). An assessment of finite sample performance of adaptive methods in density estimation. Computational Statistics & Data Analysis. 30(2). 143–168. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bengt Hamrén Breakdown of academic impact, for papers by Jane P. F. Bai Breakdown of academic impact, for papers by Omri Gottesman Breakdown of academic impact, for papers by Mark Sale Breakdown of academic impact, for papers by Marylore Chenel Breakdown of academic impact, for papers by June S. Almenoff Breakdown of academic impact, for papers by Lisa J. Benincosa Breakdown of academic impact, for papers by Hao Zhu Breakdown of academic impact, for papers by Wojciech Krzyżański Breakdown of academic impact, for papers by Rajanikanth Madabushi
Rankless by CCL
2026